Submit Deal

ARDENA HOLDING SA

HQ - Gent

Summary

Ardena operates as a pharmaceutical company. The Company offers flexible service encompassing drug substance production, dosage form manufacture, clinical logistics, bioanalysis, and dossier development. Ardena Holding serves customers worldwide.

Deals Overview

Total Deals2

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Harry Christiaens
CEO
Jeremie Trochu
CEO
Filip Van Herck
CFO

Sort

09 Jan 2020|Belgium|Biotechnology

Target: ARDENA HOLDING SA

Bidder: GHO CAPITAL PARTNERS LLP

23 Service Providers

10 Target | 12 Bidder | 1 Vendor

34 Dealmakers

6 Target | 27 Bidder | 1 Vendor

n/a

Value

14 Oct 2024|United States|Pharmaceuticals

Target: CATALENT INC (SOMERSET, NJ ORAL SOLIDS FACILITY)

Bidder: GHO CAPITAL PARTNERS LLP

4 Service Providers

2 Bidder | 2 Vendor

20 Dealmakers

14 Bidder | 6 Vendor

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy